diff --git a/wiki/pages/therapy-system.html b/wiki/pages/therapy-system.html
index 69674d78f62ccf4a3d0dd9357cf2919e01dccaae..cf93026c303d74b308e17fc16cadde66c59d37a8 100644
--- a/wiki/pages/therapy-system.html
+++ b/wiki/pages/therapy-system.html
@@ -57,7 +57,7 @@
         <h2>Design</h2>
         <hr>
         <div class="image-container" style="display: flex; flex-direction: column; align-items: center;">
-          <img src="https://static.igem.wiki/teams/5187/wiki-therapysystem-fig/fig1.png" alt="ibd_figure" class="shadowed-image" style="width: 45%; max-width: 400px;">
+          <img src="https://static.igem.wiki/teams/5187/wiki-therapysystem-fig/fig1.png" alt="ibd_figure" class="shadowed-image" style="width: 60%; max-width: 500px;">
           <p style="text-align: center; font-size: 0.9em; margin-top: 10px;">fig 1 Schematic Representation of our Experimental Design</p>
         </div>
       <p>We introduced muscone gas molecule receptors derived from mouse olfactory epithelial cells into chassis bioengineered bacteria. The muscone gas molecule receptor is a G protein coupled receptor in eukaryotic cells, and we chose Saccharomyces cerevisiaet as the chassis bioengineering bacterium. By modifying the mating pathway of Saccharomyces cerevisiae, the muscone gas molecule receptor is integrated into the signaling pathway of Saccharomyces cerevisiae. And downstream of the modified mating pathway, lactate dehydrogenase was introduced to alter the anaerobic metabolism pathway of Saccharomyces cerevisiae, synthesizing lactate for the treatment of IBD disease.</p>